Molecular diagnosis of coenzyme Q(10) deficiency

Fecha de publicación:

Autores de CIPF

Participantes ajenos a CIPF

  • Yubero, D
  • Montero, R
  • Armstrong, J
  • Santos-Ocana, C
  • Salviati, L
  • Navas, P
  • Artuch, R

Grupos de Investigación

Abstract

Coenzyme Q(10) (CoQ) deficiency syndromes comprise a growing number of neurological and extraneurological disorders. Primary-genetic but also secondary CoQ deficiencies have been reported. The biochemical determination of CoQ is a good tool for the rapid identification of CoQ deficiencies but does not allow the selection of candidate genes for molecular diagnosis. Moreover, the metabolic pathway for CoQ synthesis is an intricate and not well-understood process, where a large number of genes are implicated. Thus, only next-generation sequencing techniques (either genetic panels of whole-exome and -genome sequencing) are at present appropriate for a rapid and realistic molecular diagnosis of these syndromes. The potential treatability of CoQ deficiency strongly supports the necessity of a rapid molecular characterization of patients, since primary CoQ deficiencies may respond well to CoQ treatment.

Datos de la publicación

ISSN/ISSNe:
1473-7159, 1744-8352

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS  TAYLOR & FRANCIS AS

Tipo:
Article
Páginas:
1049-1059
PubMed:
26144946

Citas Recibidas en Web of Science: 15

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • coenzyme Q10 deficiency syndromes; functional studies in yeasts; mitochondrial diseases; muscle biopsy; next-generation sequencing

Compartir